Related Experiment Video
Updated: Mar 20, 2026
05:06
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
2.5K
Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress
Diana Naranjo1, Molly L Tanenbaum2, Esti Iturralde2
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA, USA dnaranjo@stanford.edu.
Journal of Diabetes Science and Technology
|May 29, 2016
Summary
New diabetes technology offers management tools for type 1 diabetes patients. Research indicates technology use is linked to moderate diabetes distress, with multiple daily injection users showing less positive attitudes.
Area of Science:
- Endocrinology
- Medical Technology
- Psychology
Background:
- Type 1 diabetes management increasingly involves technological aids.
- Existing literature shows varied health and psychosocial outcomes with diabetes technology.
- Understanding psychological factors is crucial for effective technology integration.
Purpose of the Study:
- To review literature on diabetes technology use and psychological factors.
- To examine psychological factors associated with technology use in type 1 diabetes patients.
- To provide insights for clinical practice and future research.
Main Methods:
- Literature review on diabetes technology and psychological correlates.
- Analysis of patient data on technology use and psychological factors.
- Human factors research approach to assess technology adoption.
Main Results:
- Patients report moderately elevated diabetes distress regardless of technology type (low-tech to high-tech).
- Technology use does not appear to significantly increase or decrease diabetes distress.
- Multiple daily injection (MDI) users exhibit less positive attitudes towards technology compared to other groups.
Conclusions:
- Diabetes technology use is widespread but associated with persistent moderate distress.
- Psychological factors, such as attitudes towards technology, vary among user groups.
- Clinical practice should consider psychological nuances in technology support for type 1 diabetes management.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
01:22Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
01:15Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
01:36Carbohydrate Metabolism
14.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.9K
01:20Pathophysiology of Diabetes
4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K